Ipsen is a pharmaceutical company based in France that develops and markets prescription medicines. Its work centres on oncology, neuroscience and rare diseases, and it supplies treatments to hospitals and specialist physicians in many countries. Products include therapies for neuroendocrine tumours, movement disorders and spasticity, along with drugs for certain cancers and rare conditions. The company also has a consumer health business that makes and sells over-the-counter products.
On this site Ipsen SA appears as a stock on the London Exchange (UK), code 0MH6, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #1743 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendFair
51/100
Mixed trend against its averages.
See the numbers →
Above 200-day average-1.3%
From 52-week high-11.7%
MomentumFair
51/100
Typical recent returns for this exchange.
See the numbers →
3-month return-6.1%
6-month return-4.1%
12-month, skipping last month28.3%
Stability (higher is calmer)Fair
69/100
Typical risk for this exchange.
See the numbers →
Volatility, 1 year (lower is calmer)30.3%
Worst drawdown, 1 year (smaller is calmer)-18.7%
LiquidityFair
63/100
Moderate trading activity.
See the numbers →
Avg daily value traded2.75M EUR
Zero-volume days0.0%
IncomeWeak
29/100
Dividend is small or irregular.
See the numbers →
Dividend yield1.0%
Years with dividends5
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 114.60 – 176.60Daily closes, split-adjusted
Signals
50-day average154.01
200-day average154.79
Golden/death cross (60d)Death, 3 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)4.73
Technical summary
Daily
Neutral
7 bullish · 1 neutral · 8 bearish
Weekly
Neutral
6 bullish · 1 neutral · 5 bearish
Monthly
Strongly bullish
6 bullish · 1 neutral · 1 bearish
Moving averages (daily)
SMA 10
147.8
Bullish
EMA 10
148.8
Bullish
SMA 20
144.8
Bullish
EMA 20
148.2
Bullish
SMA 50
154.0
Bearish
EMA 50
151.7
Bullish
SMA 100
157.3
Bearish
EMA 100
153.9
Bearish
SMA 200
154.8
Bearish
EMA 200
149.9
Bullish
Oscillators (daily)
RSI (14)
58.37
Neutral
MACD (12, 26)
-0.39
Bearish
Momentum (12)
9.77
Bullish
Stochastic %K (14)
100.0
Bearish
Williams %R (14)
0.00
Bearish
CCI (20)
155.6
Bearish
Pivot points (classic, last session)
S3
136.8
S2
140.0
S1
146.4
Pivot
149.6
R1
156.0
R2
159.2
R3
165.6
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
1.60 EUR
Yield on today's price
1.05%
Frequency
Annual
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
1.6000
1.4000
1.2000
1.2000
1.2000
1.0000
1.0000
1.0000
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in EUR. Educational only, not financial advice.
